TCL Archive Somatuline Demonstrates 65.1 Percent Of Patients Progression-Free at 96 Weeks July 25, 2014
TCL Archive An “insurgency” targets randomized trials, demands access to investigational drugs. August 5, 2005
TCL Archive Schilskly Promoted to Associate Dean At Chicago, Vogelzang To Direct Center March 5, 1999